Loading company…
Novaken develops drug formulations and technology platforms, including microneedle and inhalation products.
Novaken develops drug formulations and platforms, including soluble microneedles and inhalation formulations. Its products include medicines for conditions such as eye inflammation, intestinal infection, gastrointestinal ulcers, and pancreatic cancer. Established in 2007 and based in Guangzhou, China, the company raised venture funding from ZJVC Venture Capital and Hengqin Financial Investment in February 2025.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in